Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Lantheus Holdings (LNTH) Tops Q2 EPS by 4c, Revenues Beat
July 30, 2020 7:30 AM EDTLantheus Holdings (NASDAQ: LNTH) reported Q2 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $66.01 million versus the consensus estimate of $57.4 million.
Completed acquisition of Progenics Pharmaceuticals, Inc., adding robust portfolio of oncology therapeutics and diagnostics to pipelineWorldwide revenue of $66.0 million for the second quarter 2020, representing a decrease of 23.0% from the prior year periodNet loss of $7.0 million for the second quarter 2020, compared to net income of $6.4 million in the prior year... More